Singapore markets closed

Newland Pharmaceutical Co., Ltd. (301277.SZ)

Shenzhen - Shenzhen Delayed price. Currency in CNY
Add to watchlist
12.98+0.10 (+0.78%)
At close: 03:04PM CST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
635,058
651,437
627,364
513,837
433,123
Cost of revenue
406,200
391,923
404,007
307,818
236,315
Gross profit
228,859
259,514
223,357
206,019
196,808
Operating expenses
Research development
25,303
51,962
30,002
20,589
20,619
Selling general and administrative
-68,427
18,167
12,760
-54,402
-78,052
Total operating expenses
64,372
98,987
74,083
55,687
49,916
Operating income or loss
164,487
160,527
149,274
150,332
146,893
Interest expense
33,986
132.8493
6,882
33,527
26,583
Income before tax
145,045
181,165
142,882
131,935
137,426
Income tax expense
18,147
23,963
11,174
17,112
18,971
Income from continuing operations
126,898
157,202
131,708
114,824
118,455
Net income
127,382
158,979
132,305
114,978
118,455
Net income available to common shareholders
127,382
158,979
132,305
114,978
118,455
Basic EPS
0.65
0.56
0.61
0.55
0.57
Diluted EPS
0.65
0.56
0.61
0.55
0.57
Basic average shares
228,864
281,735
215,380
209,960
209,038
Diluted average shares
228,864
281,735
215,380
209,960
209,038